Literature DB >> 22948164

Chromosomal translocations among the healthy human population: implications in oncogenesis.

Mridula Nambiar1, Sathees C Raghavan.   

Abstract

Chromosomal translocations are characteristic features of many cancers, especially lymphoma and leukemia. However, recent reports suggest that many chromosomal translocations can be found in healthy individuals, although the significance of this observation is still not clear. In this review, we summarize recent studies on chromosomal translocations in healthy individuals carried out in different geographical areas of the world and discuss the relevance of the observation with respect to oncogenesis.

Entities:  

Mesh:

Year:  2012        PMID: 22948164     DOI: 10.1007/s00018-012-1135-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  109 in total

1.  t(14;18) Translocations and risk of follicular lymphoma.

Authors:  Charles S Rabkin; Carsten Hirt; Siegfried Janz; Gottfried Dölken
Journal:  J Natl Cancer Inst Monogr       Date:  2008

2.  Pesticide appliers with mixed pesticide exposure: G-banded analysis and possible relationship to non-Hodgkin's lymphoma.

Authors:  V F Garry; R E Tarone; L Long; J Griffith; J T Kelly; B Burroughs
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-01       Impact factor: 4.254

3.  Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis.

Authors:  Lesley F Drynan; Richard Pannell; Alan Forster; Nicole M M Chan; Florencia Cano; Angelika Daser; Terence H Rabbitts
Journal:  EMBO J       Date:  2005-08-11       Impact factor: 11.598

4.  Lack of evidence for an association between the frequency of mutants or translocations in circulating lymphocytes and exposure to radon gas in the home.

Authors:  J Cole; M H Green; B A Bridges; A P Waugh; D M Beare; D Henshaw; R Last; Y Liu; G Cortopassi
Journal:  Radiat Res       Date:  1996-01       Impact factor: 2.841

5.  Detection of t(14;18) carrying cells in bone marrow and peripheral blood from patients affected by non-lymphoid diseases.

Authors:  O Rauzy; S Galoin; J J Chale; D Adoue; J L Albarede; G Delsol; T al Saati
Journal:  Mol Pathol       Date:  1998-12

Review 6.  Pesticides and non-Hodgkin's lymphoma.

Authors:  S H Zahm; A Blair
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

7.  Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation.

Authors:  Y Tsujimoto; E Jaffe; J Cossman; J Gorham; P C Nowell; C M Croce
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

Review 8.  Chromosomal translocations in cancer.

Authors:  Mridula Nambiar; Vijayalakshmi Kari; Sathees C Raghavan
Journal:  Biochim Biophys Acta       Date:  2008-07-31

9.  MLL leukemia-associated rearrangements in peripheral blood lymphocytes from healthy individuals.

Authors:  María Sol Brassesco; Ana Paula Montaldi; Diana Ester Gras; Rosane Gomes de Paula Queiroz; Nilce Maria Martinez-Rossi; Luiz Gonzaga Tone; Elza Tiemi Sakamoto-Hojo
Journal:  Genet Mol Biol       Date:  2009-06-01       Impact factor: 1.771

10.  Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma.

Authors:  B H Ye; S Chaganti; C C Chang; H Niu; P Corradini; R S Chaganti; R Dalla-Favera
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more
  12 in total

1.  Methylation of CpG sites in BCL2 major breakpoint region and the increase of BCL2/JH translocation with aging.

Authors:  Idoia Martin-Guerrero; Elena de Prado; Maite Ardanaz; Maialen Martin-Arruti; Cristina Garcia-Orad; Isabel Guerra; Irune Ruiz; Iñaki Zabalza; Africa Garcia-Orad
Journal:  Age (Dordr)       Date:  2015-09-03

2.  Methylation of the nonhomologous end joining repair pathway genes does not explain the increase of translocations with aging.

Authors:  Idoia Martín-Guerrero; Elena de Prado; Elixabet Lopez-Lopez; Maite Ardanaz; Juan Carlos Vitoria; Luis A Parada; Cristina García-Orad; Africa García-Orad
Journal:  Age (Dordr)       Date:  2014-11-16

3.  Biochemical activity of RAGs is impeded by Dolutegravir, an HIV integrase inhibitor.

Authors:  Namrata M Nilavar; Amita M Paranjape; Sathees C Raghavan
Journal:  Cell Death Discov       Date:  2020-06-12

4.  Preventing clonal evolutionary processes in cancer: Insights from mathematical models.

Authors:  Ignacio A Rodriguez-Brenes; Dominik Wodarz
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-21       Impact factor: 11.205

5.  Copy number variation burden on asthma subgenome in normal cohorts identifies susceptibility markers.

Authors:  Sangeetha Vishweswaraiah; Avinash M Veerappa; Padukudru A Mahesh; Sareh R Jahromi; Nallur B Ramachandra
Journal:  Allergy Asthma Immunol Res       Date:  2014-12-18       Impact factor: 5.764

6.  Integrated sequence and expression analysis of ovarian cancer structural variants underscores the importance of gene fusion regulation.

Authors:  Vinay K Mittal; John F McDonald
Journal:  BMC Med Genomics       Date:  2015-07-17       Impact factor: 3.063

7.  Detection of G-quadruplex DNA using primer extension as a tool.

Authors:  Rupa Kumari; Mridula Nambiar; Shaika Shanbagh; Sathees C Raghavan
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

8.  Homology and enzymatic requirements of microhomology-dependent alternative end joining.

Authors:  S Sharma; S M Javadekar; M Pandey; M Srivastava; R Kumari; S C Raghavan
Journal:  Cell Death Dis       Date:  2015-03-19       Impact factor: 8.469

Review 9.  Personalized Cancer Risk Assessments for Space Radiation Exposures.

Authors:  Paul A Locke; Michael M Weil
Journal:  Front Oncol       Date:  2016-02-22       Impact factor: 6.244

10.  DNA double-strand break repair in Penaeus monodon is predominantly dependent on homologous recombination.

Authors:  Shikha Srivastava; Sumedha Dahal; Sharanya J Naidu; Deepika Anand; Vidya Gopalakrishnan; Rajendran Kooloth Valappil; Sathees C Raghavan
Journal:  DNA Res       Date:  2017-04-01       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.